Physician

Alexis C. Harper, APN

According to 2025 Medicare claims, Alexis Harper, APN (NPI: 1689909749) practices certified clinical nurse specialist in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is SPECIALTY PHYSICIANS OF ILLINOIS, LLC (NPI: 1124075676; TIN: 050540914) and primary practice location at 60461-1182. Harper is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), participating under the MSSP model.

Harper's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 319 traditional Medicare patients, billed 966 HCPCS/CPT codes, and received $46,344 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 5,729 prescription claims across 662 beneficiaries totaling $3,186,186 in drug costs, led by Ozempic (Semaglutide). DME data shows 827 claims. Open Payments data shows 39 records totaling $1,834. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $465,858 to $3,186,186. For DME billing, reported payments moved sharply higher in recent years, from $1,207 to $192,261.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	149	891	$35,513
2016	211	750	$40,239
2017	278	614	$22,725
2018	236	1,063	$32,641
2019	184	1,013	$32,422
2020	186	833	$26,317
2021	191	977	$34,950
2022	200	1,168	$39,686
2023	361	1,203	$49,287
2024	319	966	$46,344

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	177	1,574	$465,858
2016	186	2,416	$765,838
2017	257	1,654	$567,489
2018	208	1,259	$510,644
2019	191	1,342	$573,662
2020	227	1,721	$764,050
2021	272	2,026	$982,560
2022	291	2,167	$1,260,602
2023	628	4,049	$2,720,548
2024	662	5,729	$3,186,186

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	57	136	$2,519
2016	82	284	$8,465
2017	96	218	$3,299
2018	107	200	$3,303
2019	124	271	$9,948
2020	126	280	$10,672
2021	164	416	$26,777
2022	155	458	$52,011
2023	250	720	$94,915
2024	294	827	$195,855

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	16	16	$71
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	278	608	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	70	114	$40
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	97	221	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	454	27,431	$834,490
Jardiance	Empagliflozin	411	28,918	$546,596
Trulicity	Dulaglutide	176	9,696	$317,782
Mounjaro	Tirzepatide	139	6,710	$245,751
Januvia	Sitagliptin Phosphate	110	7,088	$128,928

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	90	383	$167,954
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	22	$9,186
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	25	$5,906
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	26	26	$5,871
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	115	237	$4,811

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$1,834	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexis C. Harper, APN?

Tedicare shows public-source Medicare data for Alexis C. Harper, APN (NPI 1689909749), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexis C. Harper, APN have ACO affiliation data?

Alexis C. Harper, APN is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550).

What billing organization is linked to Alexis C. Harper, APN?

Alexis C. Harper, APN is linked to SPECIALTY PHYSICIANS OF ILLINOIS, LLC (billing NPI 1124075676) in the available physician profile data.

Does Alexis C. Harper, APN have Open Payments data?

Alexis C. Harper, APN has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.